These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30519038)

  • 1. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
    Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
    Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIPE1 inhibits the growth of Ewing's sarcoma cells by suppressing Wnt/β-catenin signaling.
    Wang Z; Sun L; Liu S; Jiang H
    Clin Transl Oncol; 2023 May; 25(5):1332-1339. PubMed ID: 36495466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
    Li J; You T; Jing J
    Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways
    Ye C; Yu X; Liu X; Dai M; Zhang B
    Oncol Lett; 2018 Apr; 15(4):4390-4396. PubMed ID: 29541208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma.
    Ma L; Sun X; Kuai W; Hu J; Yuan Y; Feng W; Lu X
    Am J Transl Res; 2019; 11(6):3841-3849. PubMed ID: 31312393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6.
    An Y; Zhang J; Cheng X; Li B; Tian Y; Zhang X; Zhao F
    Cancer Cell Int; 2020; 20():237. PubMed ID: 32536825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-30b suppresses the progression of breast cancer through inhibition of the PI3K/Akt signaling pathway by targeting Derlin-1.
    Zhou J; Xiang AZ; Guo JF; Cui HD
    Transl Cancer Res; 2019 Feb; 8(1):180-190. PubMed ID: 35116747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating miR-374a in Hepatocarcinoma Cell Lines.
    Liu SQ; Zhang JL; Li ZW; Hu ZH; Liu Z; Li Y
    Cell Physiol Biochem; 2018; 49(6):2099-2110. PubMed ID: 30257238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
    Subbiah V; Brown RE; Jiang Y; Buryanek J; Hayes-Jordan A; Kurzrock R; Anderson PM
    PLoS One; 2013; 8(7):e68985. PubMed ID: 23922674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2.
    Zhou Y; An H; Wu G
    Onco Targets Ther; 2020; 13():9429-9441. PubMed ID: 33061429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
    Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
    PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.
    Hossain MM; Ray SK
    J Cancer Ther; 2014 Oct; 5(12):1092-1113. PubMed ID: 27547487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
    Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
    Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRASSF2 facilitates the proliferation and metastasis of colorectal cancer by mediating the activity of Wnt/β-catenin signaling pathway by regulating the miR-195-5p/FZD4 axis.
    Yang L; Bi T; Zhou S; Lan Y; Zhang R
    Anticancer Drugs; 2021 Oct; 32(9):919-929. PubMed ID: 33929991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
    Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
    Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.